Vincenza Nigro
Corporate Officer/Principal bei HANSA BIOPHARMA AB
Profil
Vincenza Nigro is currently the Vice President-Global Medical Affairs at Hansa Biopharma AB since 2018.
Prior to this, she was the Head-Medical Affairs at Veloxis Pharmaceuticals A.
Nigro holds an MBA from the Massachusetts Institute of Technology and an undergraduate degree from Fairleigh Dickinson University.
Aktive Positionen von Vincenza Nigro
| Unternehmen | Position | Beginn |
|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17.09.2018 |
Ehemalige bekannte Positionen von Vincenza Nigro
| Unternehmen | Position | Ende |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Vincenza Nigro
| Massachusetts Institute of Technology | Masters Business Admin |
| Fairleigh Dickinson University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
